Fairvalue-Calculator Fairvalue-Calculator
EN DE

Grown Rogue International Inc (GRUSF) Fair Value & Analysis

Healthcare · US · Market cap $107M

Price$0.4300
Fair Value$0.1500
Upside-65.1%
Quality88/100
Evidence: Medium Range $0.1100 – $0.1900

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Grown Rogue International Inc (GRUSF) currently trades at $0.4300, while our model-based Fair Value estimate is $0.1500 — implying the stock looks roughly 65.1% overvalued today. We read business quality at 88/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Grown Rogue International Inc., through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States. It offers flower and flower pre-rolls, as well as flower-based products. The company also produces recreational marijuana and distributes it to dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1827% Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81%

Frequently asked questions

Is Grown Rogue International Inc (GRUSF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.1500 versus a price of $0.4300 — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of GRUSF?
Our 21-model fair value for Grown Rogue International Inc is $0.1500 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.4300.
What is the quality score of GRUSF?
Grown Rogue International Inc has a Quality Score of 88/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.